As of November 11, 2024, Johnson & Johnson had a $373.3 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s ...

Johnson & Johnson shares advanced Tuesday after the pharmaceutical and medical device company posted better third-quarter sales and adjusted profit than expected. Net income fell sharply due to ...

Johnson & Johnson shares initially rose Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance. However, the stock pulled back and was ...

Johnson & Johnson’s Consumer Health segment reported a revenue of $14.6 billion in the Full-Year 2021. It is projected that, following the separation, Kenvue will generate sales in over 100 ...

A subsidiary of Johnson and Johnson is now proposing paying approximately USD 6.48 billion over 25 years as part of a settlement to cover allegations that its baby powder containing talc caused ...

I reiterate a “Buy” rating for Johnson & Johnson, driven by their robust cardiovascular device portfolio and recent acquisitions, with a fair value of $195 per share. The acquisition of V-Wave ...

Thousands of families have filed Johnson & Johnson talcum powder lawsuits alleging the company’s talc products caused cancer. They claim J&J knew about the risk of asbestos in their talc-based baby ...

Johnson & Johnson has been ordered to pay $15 million to a Connecticut man who claims he developed a rare form of cancer, mesothelioma, after using the company’s baby powder for decades. The jury in ...

Chad “Ochocinco” Johnson has split from his fiancée Sharelle Rosado. The retired NFL star, 46, is back on the market after he and the “Selling Tampa” alum called off their nearly two-year ...